pargyline has been researched along with Leucocythaemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menna, M | 1 |
| Fiorentino, F | 1 |
| Marrocco, B | 1 |
| Lucidi, A | 1 |
| Tomassi, S | 1 |
| Cilli, D | 1 |
| Romanenghi, M | 1 |
| Cassandri, M | 1 |
| Pomella, S | 1 |
| Pezzella, M | 1 |
| Del Bufalo, D | 1 |
| Zeya Ansari, MS | 1 |
| Tomašević, N | 1 |
| Mladenović, M | 1 |
| Viviano, M | 1 |
| Sbardella, G | 1 |
| Rota, R | 1 |
| Trisciuoglio, D | 1 |
| Minucci, S | 1 |
| Mattevi, A | 1 |
| Rotili, D | 1 |
| Mai, A | 1 |
1 other study available for pargyline and Leucocythaemia
| Article | Year |
|---|---|
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
Topics: Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia | 2022 |